Deutsche Bank Ag\ G1 Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.04 - $8.51 $97,081 - $204,495	-24,030 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.6 - $11.02 $7,782 - $11,284	-1,024 Reduced 4.09%	24,030 $183,000
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $19,070 - $30,351	1,877 Added 8.1%	25,054 $255,000
Q3 2021 Nov 04, 2021	SELL	$13.16 - $22.47 $9,593 - $16,380	-729 Reduced 3.05%	23,177 $311,000
Q2 2021 Aug 11, 2021	SELL	$19.57 - $26.32 $31,175 - $41,927	-1,593 Reduced 6.25%	23,906 $525,000
Q1 2021 May 13, 2021	SELL	$17.58 - $32.59 $138,407 - $256,581	-7,873 Reduced 23.59%	25,499 $613,000
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $134,462 - $249,593	12,235 Added 57.88%	33,372 $600,000
Q3 2020 Nov 12, 2020	SELL	$11.55 - $23.75 $459,747 - $945,368	-39,805 Reduced 65.32%	21,137 $245,000
Q2 2020 Aug 13, 2020	SELL	$9.57 - $24.37 $3.57 Million - $9.09 Million	-373,059 Reduced 85.96%	60,942 $1.48 Million
Q1 2020 May 14, 2020	BUY	$9.07 - $26.32 $3.82 Million - $11.1 Million	420,834 Added 3196.13%	434,001 $4.78 Million
Q4 2019 Feb 14, 2020	BUY	$20.54 - $31.0 $56,854 - $85,808	2,768 Added 26.62%	13,167 $347,000
Q3 2019 Nov 14, 2019	SELL	$22.78 - $40.58 $76,928 - $137,038	-3,377 Reduced 24.51%	10,399 $236,000
Q2 2019 Aug 14, 2019	SELL	$16.03 - $31.1 $2.7 Million - $5.24 Million	-168,459 Reduced 92.44%	13,776 $421,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $1.94 Million - $2.89 Million	134,618 Added 282.71%	182,235 $3.02 Million
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $481,283 - $1.5 Million	-29,151 Reduced 37.97%	47,617 $911,000
Q3 2018 Dec 21, 2021	BUY	$43.15 - $67.97 $1.51 Million - $2.38 Million	34,976 Added 83.69%	76,768 $4.01 Million
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $315,469 - $496,928	-7,311 Reduced 14.89%	41,792 $2.18 Million
Q2 2018 Apr 21, 2020	BUY	$35.06 - $51.17 $412,165 - $601,554	11,756 Added 31.48%	49,103 $2.13 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $70,084 - $102,288	1,999 Added 5.66%	37,347 $1.62 Million
Q1 2018 Oct 18, 2019	BUY	$19.05 - $41.76 $156,419 - $342,891	8,211 Added 30.26%	35,348 $1.31 Million
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $151,047 - $331,115	7,929 Added 41.28%	27,137 $1 Million
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $230,705 - $317,963	12,136 Added 171.61%	19,208 $380,000
Q3 2017 Nov 14, 2017	BUY	$12.53 - $27.12 $88,612 - $191,792	7,072	7,072 $175,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account